Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. S. Prince · SciRah

Researcher profile · Semantic Scholar

S. S. Prince

Share profile

S. S. Prince — researcher profile on SciRah

h-index: 11
Works: 41
Citations: 503

Most-cited papers

Immunocytochemistry for Predictive Biomarker Testing in Lung Cancer Cytology
D. Jain, A. Nambirajan, A. Borczuk, Gang Chen +9 more
2019Cancer Cytopathology103 citations Open access
Semantic Scholar
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
Kea Martin, P. Müller, J. Schreiner, S. S. Prince +4 more
2014Cancer Immunology and Immunotherapy72 citations Open access
Semantic Scholar
Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?
B. Flury, M. Weisser, S. S. Prince, L. Bubendorf +3 more
2014BMC Infectious Diseases55 citations Open access
Semantic Scholar
Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease?
B. Babouee, D. Goldenberger, L. Elzi, D. Lardinois +6 more
2013Clinical Microbiology and Infection36 citations Open access
Semantic Scholar
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
Maria Saliakoura, M. R. Sebastiano, Chiara Pozzato, Florian H. Heidel +10 more
2020Nature Cell Biology25 citations Open access
Semantic Scholar
Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial
D. Stolz, E. Papakonstantinou, M. Pascarella, K. Jahn +8 more
2023European Respiratory Journal24 citations
Semantic Scholar
Non-small cell lung carcinoma subtyping in conventional cytology: Results of the IASLC Cytology Working Group survey to determine specific cytomorphological criteria for adenocarcinoma and squamous cell carcinoma.
D. Jain, A. Nambirajan, Gang Chen, K. Geisinger +13 more
2022Journal of Thoracic Oncology23 citations Open access
Semantic Scholar
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients.
I. Alborelli, Ivana Bratic Hench, O. Chijioke, S. S. Prince +7 more
2020Lung Cancer21 citations Open access
Semantic Scholar
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.
A. Krause, L. Roma, T. Lorber, J. Habicht +6 more
2020Lung Cancer19 citations Open access
Semantic Scholar
Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho‐alveolar lavage fluids
K. Leuzinger, D. Stolz, R. Gosert, Klaudia Naegele +3 more
2020Journal of Medical Virology18 citations
Semantic Scholar
Tracing tumor heterogeneity of pleomorphic carcinoma of the lung.
L. Roma, Caner Ercan, F. Conticelli, N. Akyürek +7 more
2024Journal of Thoracic Oncology13 citations
Semantic Scholar
Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency
A. Jauch, Olivier Bignucolo, Sayuri Seki, Marie Ghraichy +33 more
2023Journal of Allergy and Clinical Immunology11 citations Open access
Semantic Scholar
A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method
D. Goldenberger, V. Hinić, S. S. Prince, M. Tamm +3 more
2016BMC Infectious Diseases11 citations Open access
Semantic Scholar
Atypical Urothelial Cells (AUC)
G. Barkan, T. Elsheikh, D. Kurtycz, S. Minamiguchi +5 more
2022The Paris System for Reporting Urinary Cytology9 citations
Semantic Scholar
Deciphering the genetic landscape of pulmonary lymphomas
Visar Vela, D. Juskevicius, S. S. Prince, G. Cathomas +9 more
2020Modern Pathology9 citations Open access
Semantic Scholar
Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort.
L. Bubendorf, M. Zoche, U. Dafni, J. Rüschoff +8 more
2022Lung Cancer7 citations Open access
Semantic Scholar
129TiP: SAKK 16/14 - anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.
S. Rothschild, A. Zippelius, S. S. Prince, Michel Gonzalez +4 more
2016Journal of Thoracic Oncology7 citations Open access
Semantic Scholar
Prediction of outcome in patients with low‐grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC
Ellen C. Obermann, S. S. Prince, A. Barascud, B. Grilli +7 more
2013Cancer Cytopathology7 citations Open access
Semantic Scholar
Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus Variants Upon Letermovir Prophylaxis Failure
Klaudia Nägele, V. Bättig, Rainer Gosert, Carla S. Walti +6 more
2024Journal of Infectious Diseases6 citations Open access
Semantic Scholar
Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma
J. Haslbauer, C. Wiegand, B. Hamelin, V. Ivanova +4 more
2024Infectious Agents and Cancer5 citations Open access
Semantic Scholar
Integration of transbronchial cryobiopsy into multidisciplinary board decision: a single center analysis of one hundred consecutive patients with interstitial lung disease
K. Hostettler, M. Tamm, L. Bubendorf, P. Grendelmeier +4 more
2021Respiratory Research5 citations Open access
Semantic Scholar
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D. König, S. S. Prince, S. Hayoz, P. Zens +19 more
2023ESMO Open4 citations Open access
Semantic Scholar
1615OPembrolizumab as second or further line treatment in relapsed malignant pleural mesothelioma: A Swiss registry
L. Mauti, D. Klingbiel, S. Schmid, H. Bouchaab +13 more
20173 citations Open access
Semantic Scholar
Plasma Osteopontin Is a Biomarker Specifically Associated with Bronchiolitis Obliterans Syndrome after HCT
Kirsten M. Williams, F. Hakim, Avi Z. Rosenberg, D. Kleiner +10 more
20163 citations Open access
Semantic Scholar
Unravelling lung adenocarcinoma with mucinous histology and its translational implications.
S. S. Prince, O. Chijioke, L. Bubendorf
2025Annals of Oncology2 citations Open access
Semantic Scholar
MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis
P. Dorn, L. Holer, D. Lardinois, A. Dutly +17 more
2023Journal of Thoracic Oncology2 citations Open access
Semantic Scholar
26PPembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)
L. Mauti, G. Rivalland, D. Klingbiel, S. Kao +16 more
20172 citations Open access
Semantic Scholar
Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
P. Jermann, I. Alborelli, K. Leonards, S. Rothschild +7 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
126TiP SAKK 16/14: Anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC): A multicenter single-arm phase II trial
S. Rothschild, A. Zippelius, S. S. Prince, Michel Gonzalez +4 more
20181 citations Open access
Semantic Scholar
Unexpected Intracameral Foreign Body during Routine Cataract Surgery
L. Eggenschwiler, S. S. Prince, L. Bubendorf, C. Walder +1 more
2017Klinische Monatsblätter für Augenheilkunde1 citations
Semantic Scholar
454P MTAP gene expression as a novel biomarker in neuroendocrine lung neoplasms
L. Roma, M. M. Brune, N. Deigendesch, S. Uzun +4 more
2026ESMO Open0 citations Open access
Semantic Scholar
Expression of HDAC2 and HDAC8 in the airways of COPD patients is associated with responsiveness to ICS: insights from the HISTORIC study
E. Papakonstantinou, M. Nowak, S. S. Prince, Daniel Soriano +5 more
2026European Respiratory Journal0 citations Open access
Semantic Scholar
Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14)
Yan Longo da Silva, Da-Pi Chiang, Laura Benecke, M. Pfaffl +21 more
2026Frontiers in Immunology0 citations Open access
Semantic Scholar
Pulmonary Mucormyosis – an Interdisciplinary Challenge
N. Bernasconi, Maurice Pradella, K. Jahn, Mathias Herrmann +4 more
2024heakthbook TIMES0 citations Open access
Semantic Scholar
484: SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC
T. Finazzi, L. Holer, Hongjian Tang, O. Riesterer +21 more
2024Radiotherapy and Oncology0 citations
Semantic Scholar
4P Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients
S. S. Prince, M. Bihl, S. Eppenberger-Castori, M. Matter +3 more
20210 citations Open access
Semantic Scholar
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial
S. Rothschild, A. Zippelius, E. Eboulet, S. S. Prince +23 more
20210 citations Open access
Semantic Scholar
Impact of thrombophilia testing on treatment decision and outcome of thromboembolism and pregnancy morbidity : a single center retrospective cohort study
S. Rothschild, I. Alborelli, K. Leonards, M. Manzo +16 more
20210 citations
Semantic Scholar
Tumor mutational burden assessed by a targeted NGS assay to predict clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
S. Rothschild, I. Alborelli, K. Leonards, L. Leuenberger +10 more
20180 citations
Semantic Scholar
Autophagy in early stage NSCLC – prognostic significance of the autophagy markers p62 and LC3B: 25P
S. Berezowska, Anna M. Schläfli, O. Adams, J. Galván +6 more
2016Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
In Memoriam - A Tribute to Alexander Meisels (1926-2014)
P. Delvenne, Agnès Delga, F. Goffin, F. Kridelka +71 more
2014Acta Cytologica0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Bubendorf×15
Invite
L. Bubendorf — researcher profile on SciRah
S. Rothschild×10
Invite
S. Rothschild — researcher profile on SciRah
A. Zippelius×6
Invite
A. Zippelius — researcher profile on SciRah
M. Tamm×6
Invite
M. Tamm — researcher profile on SciRah

×6

Invite

L. Mauti — researcher profile on SciRah

Invite

M. Früh — researcher profile on SciRah

Invite

M. Pless — researcher profile on SciRah

D. Lardinois×4

Invite

D. Lardinois — researcher profile on SciRah

I. Alborelli×4

Invite

I. Alborelli — researcher profile on SciRah

Invite

K. Leonards — researcher profile on SciRah

Invite

P. Froesch — researcher profile on SciRah

Invite

P. Russell — researcher profile on SciRah